Targeting myeloid cells in the tumor microenvironment enhances vaccine efficacy in murine epithelial ovarian cancer

Epithelial ovarian cancer (EOC) is typically diagnosed at advanced stages, and is associated with a high relapse rate. Patients in remission are ideal candidates for immunotherapy aimed at cure or prolonging disease-free periods. However, immunosuppressive pathways in the tumor microenvironment are...

Descripción completa

Detalles Bibliográficos
Autores principales: Khan, Anm Nazmul H., Kolomeyevskaya, Nonna, Singel, Kelly L., Grimm, Melissa J., Moysich, Kirsten B., Daudi, Sayeema, Grzankowski, Kassondra S., Lele, Sashikant, Ylagan, Lourdes, Webster, Gill A., Abrams, Scott I., Odunsi, Kunle, Segal, Brahm H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2015
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4484458/
https://www.ncbi.nlm.nih.gov/pubmed/25888637

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4484458/
https://www.ncbi.nlm.nih.gov/pubmed/25888637

Ejemplares similares